Major studies reveal improved treatment for children with Group 3 medulloblastoma

Three of the top Re­pub­li­cans on the House En­er­gy & Com­merce Com­mit­tee on Tues­day sent a let­ter to FDA com­mis­sion­er Rob Califf ques­tion­ing the agency’s

GSK’s new can­cer drug Jem­per­li (dostar­limab) won an FDA ap­proval on Mon­day, al­most two months ahead of its PDU­FA date, for use in cer­tain front­line

The drug pric­ing watch­dog known as the In­sti­tute for for Clin­i­cal and Eco­nom­ic Re­view on Mon­day un­veiled its an­nu­al re­port on what it says are